Survey Results: Genome editing

Scientists have recently developed a technology called CRISPR-Cas9, which enables scientists to cut and paste DNA within the genome. The tool permits genetic engineering on an unprecedented scale and at a very low cost. The technique is already being used in a variety of fields, but because of its potential to modify DNA in human embryos, it has prompted calls for a public debate about where the technology should be applied.

Researchers working with WhatIsBiotechnology are running a pilot survey to gather people's views on this new technology. Dr Lara Marks, Managing Editor of the site and historian of medicine and Dr Silvia Camporesi, bioethicist at King's College London, are leading the project.

The survey attracted feedback from 570 respondents and 1744 individual comments. This page contains a summary of the feedback from respondents. The analysis is broken down into four pages: the respondent's agreement or disagreement with seven statements about CRISPR-Cas9, their comments, keywords and phrases used to describe the technology and finally the respondents profile. Use the inline links or the links above to navigate between these pages.

If you have any questions about this survey please contact Dr Camporesi on silvia.1.camporesi@kcl.ac.uk.